Global Care Products market

Market development

eCommerce revenue development in the global OTC Drugs market

The global OTC Drugs eCommerce market is expected to increase over the next years. It is predicted to reach US$17,671.4 million by 2024 and the expected compound annual growth rate for the next four years (CAGR 2024-2028) will be 10.3%. The OTC Drugs eCommerce market is a sub-market of the Pharmaceuticals market and accounts for 26.5% within this market. Further categories within the Pharmaceuticals market are: Other Pharmaceuticals and Prescription Drugs.

eCommerce revenue development in the global OTC Drugs market

in million US$

eCommerce revenue growth in the global OTC Drugs market

in %

Net eCommerce revenue split by sub-category

in %
20202021202220232024202520262027
Revenue (in mUS$)0.00.00.00.00.00.00.00.0
Growth (in %)78.391.832.448.029.18.432.412.1

Online share

eCommerce online share of the total OTC Drugs market

The online share refers to the proportion of the retail volume that is transacted via the Internet. It includes purchases via desktop PC, tablet or smartphone, both via website or app. Only retail of physical goods is taken into account. In the global OTC Drugs retail market, the online share is 31.7% and will increase by an average of 4.0% to 37.1% by 2028.

eCommerce online share of the total OTC Drugs market

in %
20202021202220232024202520262027
Online share (in %)77.8%33.0%42.8%64.9%60.6%75.3%31.9%5.3%

Market definition

Definition of the OTC Drugs market within the Care Products market

Market definition: Care Products > Health Care > Pharmaceuticals > OTC Drugs The category OTC Drugs includes the online trade of over-the-counter (otc) pharmaceuticals (e.g. pain relievers, cold and flu remedies, allergy medications). This category does not cover perscription pharmaceuticals. All monetary figures refer to the annual gross revenue and do not factor in shipping costs.

In-scope

  • Over-the-Counter (OTC) pharmaceuticals (e.g. pain relievers, cold and flu remedies, allergy medications)

Out-of-scope

  • Perscription pharmaceuticals